share_log

醫思健康：董事名單與其角色和職能

EC HEALTHCARE: LIST OF DIRECTORS AND THEIR ROLES

香港交易所 ·  Jan 1 23:01
Summary by Moomoo AI
醫思健康（EC Healthcare）於2024年1月2日公布了其董事會成員名單及各自的角色和職能。董事會成員包括執行董事鄧志輝（主席）、呂聯煒（行政總裁）和李向榮（首席財務官），以及非執行董事陸韵晟（資訊科技總監）。此外，公司亦指定了三位獨立非執行董事：馬清楠、陸東和區雋。董事會下設有審核委員會、薪酬委員會及提名委員會，其中陸東擔任審核委員會和薪酬委員會的主席，區雋則是提名委員會的主席。該公告反映了公司治理結構的最新變動。
醫思健康（EC Healthcare）於2024年1月2日公布了其董事會成員名單及各自的角色和職能。董事會成員包括執行董事鄧志輝（主席）、呂聯煒（行政總裁）和李向榮（首席財務官），以及非執行董事陸韵晟（資訊科技總監）。此外，公司亦指定了三位獨立非執行董事：馬清楠、陸東和區雋。董事會下設有審核委員會、薪酬委員會及提名委員會，其中陸東擔任審核委員會和薪酬委員會的主席，區雋則是提名委員會的主席。該公告反映了公司治理結構的最新變動。
EC Healthcare announced on 2 January 2024 its list of Board members and their respective roles and functions. The members of the Board include Executive Directors Tang Chi-hui (Chairman), Lu Lianwei (Chief Executive Officer) and Li Xiangrong (Chief Financial Officer), as well as Non-Executive Director Lu Yun-sheng (Chief Information Technology Officer). In addition, the Company has appointed three independent non-executive directors: Ma Qingnan, Lu Dong and Hu Chun. Under the Board of Directors there is an Audit Committee, a Remuneration Committee and a Nominating Committee, with Kung Hung serving as Chairman of the Audit Committee and the Remuneration Committee, and Zhu Chun being the Chairman of the Nominating Committee. The announcement reflects recent changes in the corporate governance structure.
EC Healthcare announced on 2 January 2024 its list of Board members and their respective roles and functions. The members of the Board include Executive Directors Tang Chi-hui (Chairman), Lu Lianwei (Chief Executive Officer) and Li Xiangrong (Chief Financial Officer), as well as Non-Executive Director Lu Yun-sheng (Chief Information Technology Officer). In addition, the Company has appointed three independent non-executive directors: Ma Qingnan, Lu Dong and Hu Chun. Under the Board of Directors there is an Audit Committee, a Remuneration Committee and a Nominating Committee, with Kung Hung serving as Chairman of the Audit Committee and the Remuneration Committee, and Zhu Chun being the Chairman of the Nominating Committee. The announcement reflects recent changes in the corporate governance structure.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more